Some studies found serum levels of IL-31 to be significantly elevated compared to healthy controls [95–97], whereas another study showed that translational and transcriptional expression levels of IL-31 were very low or undetectable in CTCL patients [98]. Here, IL31 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.